The role, identity and connectivity of the payer is shifting in the face of global cost containment that is seeing all major pharma markets globally adopt new healthcare infrastructures geared around delivering economically efficient longer term positive outcomes. Clinicians and traditional payers combine within these emerging networks designed to assess cost-effectiveness at the national, regional and local level, presenting new engagement challenges and evidence requirements for the pharma industry.
Gain valuable insight into the EU5 and US country specific market trends; governmental regulation and formulary committee decision making processes; pricing and reimbursement regulations; why payers are vital to your research; helpful hints and recruitment considerations.
Download the white paper. Registration is required.